Millions with end-stage kidney disease depend on hemodialysis as a critical lifeline. Despite advances, determining precise fluid removal remains a challenge, risking instability. Current methods often fail to prevent adverse events like hypotension, affecting nearly half of patients. Boston University and Boston Medical Center researchers propose a novel solution using near-infrared light to monitor real-time tissue water content during dialysis. Their study, published in Biophotonics Discovery, suggests this method could allow clinicians to anticipate and prevent complications.
Existing tools like Crit-Line focus on blood hematocrit changes, neglecting the extravascular compartments where most body water resides. This oversight can lead to fluid imbalance and complications. The Boston research team developed a device combining frequency-domain and broadband continuous-wave spectroscopy to measure tissue absorption and scattering, providing a detailed view of tissue composition. This device, attached to patients’ calves, recorded continuous optical data during dialysis, capturing changes linked to hydration and tissue composition.
The study involved 27 adult inpatients, typical of dialysis populations with high rates of hypertension and cardiovascular disease. Researchers monitored optical changes and patient symptoms, focusing on the tissue water ratio. This metric, representing water content relative to tissue composition, distinguished patients who experienced complications from those who remained stable. The optical system detected physiological changes earlier than current tools, offering a potential early warning system for clinicians.
Dialysis clinics currently lack real-time tools for managing fluid-related complications. This study suggests that noninvasive monitoring of interstitial water could enable preemptive adjustments to ultrafiltration rates. While the study’s small cohort and simplified tissue model require further validation, the optical approach offers broad potential beyond dialysis, including managing heart failure edema and monitoring hydration in athletes.
The ability to monitor tissue water in real time could revolutionise hemodialysis, providing clinicians with insights into patient-specific physiological responses. This innovative approach may significantly improve patient safety and treatment efficacy, offering a clearer view of the complex dynamics of fluid management.
